Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Psychopharmacology|January 1, 1993
A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorderY Lecrubier, A J Puech, A Azcona, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Effects of a selective partial D1 agonist, CY 208-243, in de novo patients with Parkinson diseaseM Emre, U K Rinne, A Rascol, et al.
Clinical Neuropharmacology|February 1, 1989
The antiparkinsonian activity of CQA 206-291, a new D2 dopamine receptor agonistJ A Temlett, N P Quinn, C D Marsden, et al.
Neurology|April 1, 1990
Blood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective D1 agonist (CY 208-243)G Durrieu, J M Senard, O Rascol, et al.
Psychopharmacology|January 1, 1993
Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new atypical antipsychotic drugs, in schizophrenic patientsF Duval, M C Mokrani, J P Macher, et al.
Clinical Neuropharmacology|August 1, 1990
CQA 206-291: a novel dopamine agonist in the treatment of Parkinson's diseaseO Rascol, N Fabre, H Teräväinen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's diseaseJ A Temlett, N P Quinn, P G Jenner, et al.
Pageof 2